DZ BANK upgraded Carl Zeiss Meditec (ETR:AFX) to Buy in a statement released earlier today.
- Updated: September 18, 2016
DZ BANK has upgraded Carl Zeiss Meditec(ETR:AFX) to Buy in a report released on 8/15/2016.
Having a price of 33.29EUR, Carl Zeiss Meditec (ETR:AFX) traded 0.00% even on the day. The last stock close is up 0.00% from the two hundred day average, compared to the Standard & Poor’s 500 Index which has decreased -0.01% over the same time. The company has logged a 50-day moving average of 0.00EUR and two hundred day average of 0.00EUR. 0 shares of Carl Zeiss Meditec exchanged hands, from ann avg. volume of 0
See Graphic Below:
Carl Zeiss Meditec has a 52 week low of 0.00EUR and a 52 week high of 0.00EUR and has a total market value of 0.0 EUR.
General Company Details For Carl Zeiss Meditec (ETR:AFX)
Carl Zeiss Meditec AG is a Germany-based medical technology solutions supplier. The Company operates, along with its subsidiaries, in two business areas: Ophthalmology and Microsurgery. The Ophthalmology business area is subdivided into two business units: the Ophthalmology systems unit covers a range of laser and diagnostic systems for ophthalmology, and the Surgical Ophthalmology unit combines the Company’s activities in the field of ophthalmic implants and disposables. The Microsurgery business area offers surgical microscopes and visualization solutions for ear, nose and throat surgery, or neurosurgery. Its microsurgery products are mainly used as supporting equipment for the removal of tumors, as well as the treatment of vascular diseases and functional disorders. In January 2014, it acquired Optronik Optik ve Elektronik Cihazlar Ticaret ve Sanayi AS, a wholesaler of ophthalmology products, as well as a 100% stake in Aaren Scientific Inc, and a producer of intraocular lenses.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with MarketBeat.com's FREE daily email newsletter.